← Back to Analyst Consensus 
WST Buy
WEST PHARMACEUTICAL SERVICES INC
Current Price —
Implied Upside —
Analysts 22
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 22, 2026 | Morgan Stanley | upgrade | Equal-Weight → Overweight | — | 54% |
| Sep 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 3, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 27, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 13, 2026 | BNP Paribas | initiate | — → Outperform | — | 51% |
| Jul 9, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jul 2, 2026 | Keybanc | maintain | Overweight → Overweight | — | 53% |
| Jun 9, 2026 | Barclays | upgrade | Equal-Weight → Overweight | — | 53% |
| Jun 2, 2026 | Stephens & Co. | reiterate | Overweight → Overweight | — | 54% |
| May 29, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 27, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Apr 14, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Feb 13, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $265 | 53% |
| Feb 3, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $320 | 58% |
| Dec 2, 2025 | Morgan Stanley | initiate | — → Equal-Weight | $285 | 54% |
| Oct 29, 2025 | TD Cowen | initiate | — → Buy | $350 | 54% |
| Oct 27, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $325 | 53% |
| Oct 24, 2025 | UBS | maintain | Buy → Buy | $355 | 54% |
| Oct 24, 2025 | Keybanc | maintain | Overweight → Overweight | $350 | 53% |
| Oct 23, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $390 | 58% |
| Oct 2, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $275 | 53% |
| Sep 15, 2025 | Rothschild & Co | initiate | — → Buy | $311 | 56% |
| Jul 25, 2025 | UBS | maintain | Buy → Buy | $320 | 54% |
| Jul 25, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $350 | 58% |
| Jul 25, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $260 | 53% |
| Jun 24, 2025 | Barclays | initiate | — → Equal-Weight | $245 | 53% |
| Mar 18, 2025 | Evercore ISI Group | initiate | — → Outperform | $275 | 58% |
| Feb 14, 2025 | Keybanc | maintain | Overweight → Overweight | $325 | 53% |
| Jan 8, 2025 | Citigroup | initiate | — → Buy | $400 | 54% |
| Dec 13, 2024 | B of A Securities | maintain | Buy → Buy | $355 | 53% |
| Dec 13, 2024 | Wolfe Research | initiate | — → Peer Perform | $0 | 53% |
| Dec 12, 2024 | UBS | upgrade | Neutral → Buy | $390 | 54% |
| Feb 16, 2024 | UBS | maintain | Neutral → Neutral | $375 | 54% |
| Feb 13, 2024 | Keybanc | maintain | Overweight → Overweight | $470 | 53% |
| Feb 7, 2024 | Jefferies | upgrade | Hold → Buy | $536 | 52% |
| Oct 27, 2023 | Stephens & Co. | maintain | Overweight → Overweight | $390 | 54% |
| Aug 30, 2023 | Keybanc | maintain | Overweight → Overweight | $440 | 53% |
| Aug 21, 2023 | Keybanc | maintain | Overweight → Overweight | $415 | 53% |
| Jul 28, 2023 | Keybanc | maintain | Overweight → Overweight | $385 | 53% |
| Jul 17, 2023 | Stephens & Co. | maintain | Overweight → Overweight | $420 | 54% |
| Jun 16, 2023 | B of A Securities | upgrade | Neutral → Buy | $405 | 53% |
| Apr 11, 2023 | Stephens & Co. | upgrade | Equal-Weight → Overweight | $400 | 54% |
| Feb 17, 2023 | Keybanc | maintain | — → Overweight | $375 | 53% |
| Dec 14, 2022 | Deutsche Bank | initiate | — → Hold | $250 | 57% |
| Dec 2, 2022 | Keybanc | maintain | — → Overweight | $315 | 53% |
| Nov 30, 2022 | UBS | initiate | — → Neutral | $250 | 54% |
| Oct 28, 2022 | B of A Securities | downgrade | Buy → Neutral | $250 | 53% |
Price Target Trend
Jul 25, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days